Content Paint

pharma

Merck vows to ramp up “data, digital, analytics” use

Multinational has spun up its own AI SaaS accessible via API and trained on proprietary data.

Merck says it's releasing a new AI-powered SaaS - trained on proprietary data

CTO says new platform "enables any laboratory to count on generative AI to identify the most suitable drug-like candidates in a vast chemical space."

AI and drug discovery: "This is the start of things..."

"It's the data, stupid"

Search the site

Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Great! You've successfully signed up.
Great! You've successfully signed up.
Welcome back! You've successfully signed in.
Success! You now have access to additional content.